ALPS Medical Breakthroughs ETF Rating $39.07 +0.81 (+2.12%) (As of 01:12 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy2.91Holdings in SBIO have an aggregate rating of Moderate Buy based on 471 analyst ratings issued in the past year covering 50 companies (81.5% of the portfolio).SBIO Aggregate Price Target$58.3950.68% UpsideHigh Prediction$81.68Average Prediction$58.39Low Prediction$38.83Holdings in SBIO have an aggregate price target of $58.39 and a range of $38.83 to $81.68 covering 50 companies (81.5% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy28 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.58%RNAAvidity Biosciences$44.88+7.2%2.0236 of 5 stars3.00$63.22 40.9%93.30%KRYSKrystal Biotech$169.25-4.0%4.6874 of 5 stars3.00$196.75 16.2%9News CoverageGap Down3.17%ACLXArcellx$89.19+3.5%1.3143 of 5 stars3.08$89.75 0.6%13Upcoming Earnings3.13%CORTCorcept Therapeutics$50.98+7.1%4.912 of 5 stars3.00$65.25 28.0%5Earnings ReportAnalyst Revision2.97%CRNXCrinetics Pharmaceuticals$57.03+0.6%3.0026 of 5 stars2.91$68.55 20.2%11Negative News2.94%ALKSAlkermes$26.64+0.6%4.8935 of 5 stars2.50$34.90 31.0%102.73%IMVTImmunovant$29.42+0.1%2.6444 of 5 stars3.00$48.10 63.5%112.44%DNLIDenali Therapeutics$27.53+1.8%4.3799 of 5 stars2.73$38.90 41.3%11Upcoming EarningsAnalyst Forecast2.32%MRUSMerus$51.77+2.9%1.9959 of 5 stars3.15$86.70 67.5%13Analyst Forecast2.02%XENEXenon Pharmaceuticals$42.40+1.7%3.5675 of 5 stars3.08$57.45 35.5%12Positive News2.00%EWTXEdgewise Therapeutics$33.98-0.1%1.9827 of 5 stars3.00$35.60 4.8%5Positive News1.98%FOLDAmicus Therapeutics$11.48+0.1%4.4329 of 5 stars2.89$17.13 49.2%9Upcoming Earnings1.79%MLTXMoonLake Immunotherapeutics$45.56-2.6%2.0325 of 5 stars2.82$80.45 76.6%11Positive News1.77%VRNAVerona Pharma$37.94+8.5%1.1431 of 5 stars3.00$39.33 3.7%6Gap Down1.77%PTCTPTC Therapeutics$40.69+0.5%2.6097 of 5 stars2.33$40.08 -1.5%15Upcoming Earnings1.73%PTGXProtagonist Therapeutics$47.53+1.6%3.0072 of 5 stars3.17$52.83 11.2%6Upcoming Earnings1.67%IDYAIDEAYA Biosciences$30.00+4.9%4.3199 of 5 stars3.07$55.45 84.8%15Upcoming Earnings1.67%APGEApogee Therapeutics$55.50+1.9%2.5481 of 5 stars3.00$78.50 41.4%6Upcoming Earnings1.66%CGONCG Oncology$36.52+1.7%3.049 of 5 stars3.11$63.88 74.9%91.64%NMRANeumora Therapeutics$11.74+5.1%1.9845 of 5 stars2.86$22.83 94.5%71.62%ZLABZai Lab$31.05+1.9%2.8749 of 5 stars3.00$52.50 69.1%4Gap Down1.59%ACADACADIA Pharmaceuticals$14.79-0.1%4.5087 of 5 stars2.65$25.56 72.8%17Upcoming Earnings1.58%GERNGeron$4.16+1.2%3.9527 of 5 stars3.00$6.94 66.9%10Upcoming Earnings1.56%AGIOAgios Pharmaceuticals$44.78-0.2%4.3293 of 5 stars2.50$52.33 16.9%8Analyst Forecast1.47%VERAVera Therapeutics$45.29+3.4%2.5181 of 5 stars3.10$53.56 18.3%101.44%KROSKeros Therapeutics$60.64+1.2%3.4467 of 5 stars3.00$89.11 47.0%11Positive News1.37%AKROAkero Therapeutics$32.62+0.9%3.886 of 5 stars2.86$43.20 32.4%7Upcoming EarningsInsider SellingPositive News1.32%SLNOSoleno Therapeutics$56.39+0.9%3.9296 of 5 stars3.13$69.86 23.9%8Upcoming Earnings1.31%LBPHLongboard Pharmaceuticals$59.44-0.4%1.7159 of 5 stars2.44$59.56 0.2%9Upcoming Earnings1.30%NTLAIntellia Therapeutics$15.18+2.5%4.278 of 5 stars2.76$59.13 289.5%171.27%VCELVericel$44.35+0.8%2.6627 of 5 stars3.00$57.71 30.1%7Upcoming Earnings1.25%CLDXCelldex Therapeutics$25.61-0.3%2.2324 of 5 stars2.89$62.25 143.1%9Upcoming Earnings1.23%ARVNArvinas$27.25+1.3%2.0404 of 5 stars2.87$56.92 108.9%15Earnings ReportAnalyst Revision1.23%GLPGGalapagos$26.880.0%0.6638 of 5 stars1.83$30.75 14.4%6Analyst ForecastAnalyst Revision1.23%MIRMMirum Pharmaceuticals$41.02+1.5%4.4407 of 5 stars3.17$56.82 38.5%12Upcoming EarningsPositive News1.16%MNKDMannKind$7.28+1.5%1.7829 of 5 stars3.14$8.67 19.0%7Upcoming Earnings1.10%SNDXSyndax Pharmaceuticals$19.31+1.7%3.9096 of 5 stars2.90$35.90 85.9%10Upcoming Earnings1.10%NAMSNewAmsterdam Pharma$18.24+2.4%2.8469 of 5 stars3.00$33.80 85.3%7Upcoming Earnings1.06%IMCRImmunocore$31.31-1.2%1.8415 of 5 stars2.69$74.36 137.5%13Upcoming Earnings1.01%RCUSArcus Biosciences$15.95+2.9%2.7191 of 5 stars3.00$33.67 111.1%10Upcoming Earnings0.99%BCRXBioCryst Pharmaceuticals$7.10-15.8%3.9174 of 5 stars2.83$14.17 99.5%6News CoverageGap DownHigh Trading Volume0.97%SPRYARS Pharmaceuticals$15.49+1.5%2.8506 of 5 stars3.33$24.00 54.9%60.93%VRDNViridian Therapeutics$22.81+2.4%2.6374 of 5 stars2.82$35.80 56.9%11Upcoming Earnings0.91%TARSTarsus Pharmaceuticals$47.43+0.3%1.3978 of 5 stars3.00$51.60 8.8%70.91%IRONDisc Medicine$59.15+25.5%3.774 of 5 stars3.00$73.10 23.6%10Analyst UpgradeGap UpHigh Trading Volume0.89%KURAKura Oncology$17.85+5.7%3.8103 of 5 stars3.00$28.83 61.5%8Upcoming Earnings0.86%DAWNDay One Biopharmaceuticals$14.98+2.3%1.7755 of 5 stars2.88$35.71 138.4%8Earnings ReportAnalyst Revision0.86%XNCRXencor$21.56+1.4%4.0499 of 5 stars3.00$34.78 61.3%9Upcoming Earnings0.83%PRAXPraxis Precision Medicines$72.09+5.5%3.0263 of 5 stars2.89$145.67 102.1%9Upcoming Earnings0.82%COGTCogent Biosciences$11.85+1.1%1.6539 of 5 stars2.71$14.67 23.8%7Upcoming EarningsAnalyst Forecast This page (NYSEARCA:SBIO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.